MacroGenics reported $9.28M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
AbbVie USD 4.53B 345M Mar/2025
Amgen USD 6.58B 146M Jun/2025
AstraZeneca USD 6.47B 583M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Daiichi Sankyo JPY 514.91B 39.56B Mar/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Genmab DKK 13M 1000K Jun/2025
Geron USD 69.12M 12.9M Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
J&J USD 12.66B 215M Mar/2025
MacroGenics USD 9.28M 9.28M Jun/2025
Merck USD 6.6B 405M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Xencor USD 0 0 Jun/2020